Basilea Pharmaceutica (OTCMKTS:BPMUF) Sets New 12-Month High – What’s Next?

Basilea Pharmaceutica AG (OTCMKTS:BPMUF) shares hit a new 52-week high on Monday . The stock traded as high as $54.00 and last traded at $54.00, with a volume of 100 shares. The stock had previously closed at $52.83.

Basilea Pharmaceutica Trading Up 2.2 %

The company has a current ratio of 4.10, a quick ratio of 3.27 and a debt-to-equity ratio of 5.70. The stock’s fifty day simple moving average is $52.83 and its 200-day simple moving average is $52.54.

Basilea Pharmaceutica Company Profile

Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.